Apr 27, 2018

Quantification of DNA methylation and hydroxymethylation in Alzheimer's disease mouse model using LC-MS/MS

Journal of Mass Spectrometry : JMS
Qionglin HuangChun Cai


Ambiguous alteration patterns of 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) involved in Alzheimer's disease (AD) obstructed the mechanism investigation of this neurological disorder from epigenetic view. Here, we applied a fully quantitative and validated LC-MS/MS method to determine genomic 5mC and 5hmC in the brain cortex of 3 month-aged (12, 15, and 18 month) AD model mouse and found significant increases of 5mC and 5hmC levels in different months of AD mouse when compared with age-matched wild-type control and exhibited rising trend from 12-month to 18-month AD mouse, thereby supporting genomic DNA methylation and hydroxymethylation were positively correlated with developing AD.

  • References27
  • Citations


  • This paper may not have been cited yet.

Mentioned in this Paper

Familial Alzheimer Disease (FAD)
DNA Methylation [PE]
Cortex Bone Disorders
Adrenal Cortex Diseases
DNA Methylation
Alzheimer's Disease
Tandem Mass Spectrometry
Study of Epigenetics

Related Feeds

Alzheimer's Disease: Genetics

Alzheimer's disease is a chronic neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations here.

Alzheimer's Disease: Animal models

Alzheimer's disease is a chronic neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Alzheimer's Disease: Genes&Microglia

Genes and microglia are associated with the risk of developing and the progression of conditions such as Alzheimer's Disease (AD). Here are the latest discoveries pertaining to this disease.

© 2020 Meta ULC. All rights reserved